Nanofibrillated cellulose/cyclodextrin based 3D scaffolds loaded with raloxifene hydrochloride for bone regeneration.


Journal

International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578

Informations de publication

Date de publication:
01 Aug 2020
Historique:
received: 15 02 2020
revised: 02 04 2020
accepted: 05 04 2020
pubmed: 15 4 2020
medline: 12 3 2021
entrez: 15 4 2020
Statut: ppublish

Résumé

This study intended to design novel nanofibrillated cellulose/cyclodextrin-based 3D scaffolds loaded with raloxifene hydrochloride for bone regeneration. The scaffolds were prepared using two different types of cyclodextrins namely; beta-cyclodextrin and methyl-beta-cyclodextrin. The prepared scaffolds were evaluated by characterizing their porosity, compressive strength, in-vitro drug release, FT-IR and XRD as well as their morphological properties using SEM. Results presented that the prepared scaffolds were highly porous, additionally, the scaffold containing drug/beta-cyclodextrin kneaded complex (SC5) showed the most controlled drug release pattern with the least burst effect and reached almost complete release at 480 h. The in-vitro cytocompatibility and regenerative effect of the chosen scaffold (SC5) was assessed using Saos-2 cell line. Results proved that SC5 was biocompatible. Moreover, it enhanced the cell adhesion, alkaline phosphatase enzyme expression and calcium ion deposition which are essential factors for bone mineralization. The obtained observations presented a novel, safe and propitious approach for bone engineering.

Identifiants

pubmed: 32289405
pii: S0141-8130(20)32873-7
doi: 10.1016/j.ijbiomac.2020.04.019
pii:
doi:

Substances chimiques

Biomarkers 0
Bone Density Conservation Agents 0
Cyclodextrins 0
Raloxifene Hydrochloride 4F86W47BR6
Cellulose 9004-34-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

704-716

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Rabab Kamel (R)

Pharmaceutical Technology Department, National Research Centre, Cairo, Egypt.

Nahla A El-Wakil (NA)

Cellulose and Paper Department, National Research Centre, Cairo, Egypt.

AbdelFattah A Abdelkhalek (AA)

Department of Microbiology of Supplementary General Science, Faculty of Oral & Dental Medicine, Future University in Egypt, Cairo, Egypt.

Nermeen A Elkasabgy (NA)

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Kasr El-Aini Street, Cairo 11562, Egypt. Electronic address: nermeen.ahmed.elkasabgy@pharma.cu.edu.eg.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH